RI-OR2-TAT

RI-OR2-TAT
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TP3015-10mg 10 mg - - -

7 - 10 business days*

-
TGM-TP3015-50mg 50 mg - - -

7 - 10 business days*

-
 
Description: RI-OR2-TAT is a brain-penetrable inhibitor targeting beta-amyloid (beta-Amyloid)... more
Product information "RI-OR2-TAT"
Description: RI-OR2-TAT is a brain-penetrable inhibitor targeting beta-amyloid (beta-Amyloid) oligomerization. It is engineered by integrating the HIV protein transduction domain TAT into RI-OR2. RI-OR2-TAT binds to Abeta42 fibrils with a Kd value of 58-125 nM. It reduces Abeta aggregation and plaque levels, diminishes microglial activation and oxidative damage, and enhances the number of young neurons in the dentate gyrus. Target: Others. Smiles: [C@H](CC1=CC=CC=C1)(NC([C@@H](CC2=CC=CC=C2)NC(CNC([C@@H](CCCNC(=N)N)NC(C)=O)=O)=O)=O)C(N[C@@H](C(N[C@@H](C(N[C@@H](C(NCC(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(N[C@@H](C(NCC(N[C@H](CC3=CC=C(O)C=C3)C(N)=O)=O)=O)CCCNC(=N)N)=O)CCCCN)=O)CCCCN)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCC(N)=O)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)=O)CCCCN)=O)CC(C)C)=O)[C@@H](C)C)=O
Supplier: TargetMol
Supplier-Nr: TP3015

Properties

Conjugate: No
MW: 2662.16 D
Formula: C117H201N49O23

Database Information

Handling & Safety

Storage: +4°C
Shipping: +20°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "RI-OR2-TAT"
Write a review
or to review a product.
Viewed